Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001104659-25-050116

Director acquired 75,572 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Adiumentum Capital Fund I LP · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-16 Grant or award : show line 1 in the form +75,572 $6.61 $499,531 1,209,395 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-16 Grant or award : show line 2 in the form Warrants (right to buy) +227,000 $6.61 $1,500,447 377,193 D
Loading xslF345X05/tm2515303-1_4seq1.xml…